Alexander M Seifalian

InstitutionNanotechnology and Regenerative Medicine Commercialization Centre (NanoRegMed Ltd)
AddressLondon.
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in January 2021
    All Publications
    Bar chart showing 323 publications over 20 distinct years, with a maximum of 31 publications in 2011 and 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tavakol S, Tavakol H, Alavijeh MS, Seifalian A. The World Against Versatile SARS-Cov-2 Nanomachines: Mythological or Reality? Curr Stem Cell Res Ther. 2022; 17(1):43-57. PMID: 34254928.
      Citations: Article has an altmetric score of 1    Fields:    Translation:Humans
    2. Ebrahimi Sadrabadi A, Bereimipour A, Jalili A, Gholipurmalekabadi M, Farhadihosseinabadi B, Seifalian AM. The risk of pancreatic adenocarcinoma following SARS-CoV family infection. Sci Rep. 2021 06 21; 11(1):12948. PMID: 34155232.
      Citations: 1   Article has an altmetric score of 545    Fields:    Translation:HumansCells
    3. Tavakol S, Seifalian AM. Vitamin E at a high dose as an anti-ferroptosis drug and not just a supplement for COVID-19 treatment. Biotechnol Appl Biochem. 2021 May 02. PMID: 33938041.
      Citations: 3   Article has an altmetric score of 27    Fields:    
    4. Tavakol S, Zahmatkeshan M, Mohammadinejad R, Mehrzadi S, Joghataei MT, Alavijeh MS, Seifalian A. The role of nanotechnology in current COVID-19 outbreak. Heliyon. 2021 Apr; 7(4):e06841. PMID: 33880422.
      Citations: 2   Article has an altmetric score of 23    
    5. Tavakol S, Alavijeh MS, Seifalian AM. COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus. Curr Pharm Des. 2021; 27(13):1553-1563. PMID: 33100195.
      Citations: 5   Article has an altmetric score of 25    Fields:    Translation:Humans
    6. Seifalian AM, Tavakol S. Preventive and Therapeutic Strategies to Fight COVID-19. Curr Pharm Des. 2021; 27(13):1547-1548. PMID: 34060994.
      Citations: Article has an altmetric score of 3    Fields:    Translation:Humans